Brazil health regulator Anvisa's technical staff recommend against importing Russia's Sputnik vaccine

The Brazilian health regulator's technical staff on Monday recommended against approving imports of the Russian-made Sputnik V COVID-19 vaccine requested by governors battling against a deadly second wave of the virus. The recommendations by Anvisa's technical staff will be taken into account by the regulator's board, which will announce its decision later on Monday. Anvisa had previously said there were 'critical issues' surrounding the vaccine's effectiveness and safety that needed clarifying.